Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Suspended × apatinib × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Unknown 165 Completed 42 Recruiting 39 Not yet recruiting 22 Active not recruiting 10 Withdrawn 7 Terminated 7 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Osteosarcoma 1 Drug-Related Side Effects and Adverse Reactions 1

Interventions

Specimen Handling 9 Magnetic Resonance Spectroscopy 8 Biopsy 8 pembrolizumab 5 Paclitaxel 4 Nivolumab 4 Cisplatin 4 Capecitabine 4 spartalizumab 3 Vincristine 3 Radiosurgery 3 Irinotecan 3 Fluorouracil 3 Etoposide 3 Docetaxel 3 Dexamethasone 3 Cyclophosphamide 3 Bevacizumab 3 trifluridine tipiracil drug combination 2 lenvatinib 2 daratumumab 2 balstilimab 2 atezolizumab 2 Taxes 2 Radiation 2 Prednisone 2 Pemetrexed 2 Oxaliplatin 2 Mitoxantrone 2 Leucovorin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04824352 2024-05-14

AIEO

Peking University People's Hospital

Phase 2 Suspended

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon ⚡